References of "Osteoporosis International"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailComment on Freemantle et al. : Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatements
Brandi, ML; Reginster, Jean-Yves ULg; Rizzoli, R et al

in Osteoporosis International (2013), 24(6), 1929-30

Detailed reference viewed: 15 (5 ULg)
Full Text
Peer Reviewed
See detailStrontium ranelate effect on knee osteoarthritis progression : a MRI analysis
Genant, HK; Zaim, S; Guermazi, A et al

in Osteoporosis International (2013), 24(1), 312-313

Detailed reference viewed: 25 (2 ULg)
Full Text
Peer Reviewed
See detailNutrition and bone health : turning beliefs into knowledge for healthy behaviour
Brandi, ML; Reginster, Jean-Yves ULg

in Osteoporosis International (2013), 24(1), 388-389

Detailed reference viewed: 19 (3 ULg)
Full Text
Peer Reviewed
See detailStrontium ranelate prevents radiological progression in patients with primary knee osteoarthritis
Cooper, C; Berembaum, F; Nash, P et al

in Osteoporosis International (2013), 24(1), 306-307

Detailed reference viewed: 15 (2 ULg)
Full Text
Peer Reviewed
See detailThe general approach to the patient with osteoarthritis : is a treatment algorithm feasible ?
Reginster, Jean-Yves ULg

in Osteoporosis International (2013), 24(1), 385

Detailed reference viewed: 6 (2 ULg)
Full Text
Peer Reviewed
See detailPharmacological management : osteoporosis and osteoarthritis, similarities and differences
Reginster, Jean-Yves ULg

in Osteoporosis International (2013), 24(1), 75-76

Detailed reference viewed: 5 (2 ULg)
Full Text
Peer Reviewed
See detailInhibition of sclerostin with romosozumab in postmenopausal women with low BMD : phase 2 trial results
McClung, M; Grauer, A; Boonen, S et al

in Osteoporosis International (2013), 24(1), 38-39

Detailed reference viewed: 87 (3 ULg)
Full Text
Peer Reviewed
See detailIndirect comparison of bazedoxifene vs. oral bisphosphonates for the prevention of vertebral fractures in postmenopausal osteoporotic women
Reginster, Jean-Yves ULg; Ellis, AG; Luo, X et al

in Osteoporosis International (2013), 24(1), 37

Detailed reference viewed: 37 (7 ULg)
Full Text
Peer Reviewed
See detailRelationship between use of antidepressants and risk of fractures: a meta-analysis
Rabenda, Véronique ULg; Nicolet, Delphine ULg; Beaudart, Charlotte ULg et al

in Osteoporosis International (2013), 24

Summary It has been shown that antidepressants would have a direct action on bone metabolism and would be associated with increased fracture risk. Results from this large meta-analysis show that both ... [more ▼]

Summary It has been shown that antidepressants would have a direct action on bone metabolism and would be associated with increased fracture risk. Results from this large meta-analysis show that both SSRIs and TCAs are associated with a moderate and clinically significant increase in the risk of fractures of all types. Introduction This study seeks to investigate the relationship between use of antidepressants and the risk of fracture. Methods An exhaustive systematic research of case–control and cohort studies published or performed between 1966 and April 2011 that reported risk estimates of fracture associated with use of antidepressants was performed using MEDLINE, PsycINFO, and the Cochrane Systematic Review Database, manual review of the literature, and congressional abstracts. Inclusion, quality scoring, and data abstraction were performed systematically by three independent reviewers. Results A total of 34 studies (n01,217,464 individuals) were identified. Compared with non-users, the random effects pooled RR of fractures of all types, among antidepressant users, were 1.39 (95%CI 1.32–1.47). Use of antidepressants were associated with a 42 %, 47 %, and 38 % risk increase in non-vertebral, hip, and spine fractures, respectively ([For non-vertebral fractures: RR01.42, 95%CI 1.34–1.51]; [For hip fractures: RR01.47, 95%CI 1.36–1.58]; [For spine fractures: RR01.38, 95%CI 1.19–1.61]). Studies examining SSRI use showed systematically a higher increase in the risk of fractures of all types, non-vertebral, and hip fractures than studies evaluating TCA use. Conclusions Results from this large meta-analysis show that both SSRIs and TCAs are associated with a moderate and clinically significant increase in the risk of fractures of all types. [less ▲]

Detailed reference viewed: 46 (23 ULg)
Full Text
Peer Reviewed
See detailHypovitaminosis D and osteoporosis in burn patients: are the current practices enough ?
ROUSSEAU, Anne-Françoise ULg; LEDOUX, Didier ULg; DAMAS, Pierre ULg et al

in Osteoporosis International (2013), 24(Suppl 1), 377

Detailed reference viewed: 46 (17 ULg)
Full Text
Peer Reviewed
See detailPatients' preferences for osteoporosis drug therapy : a discrete choice experiment
Hiligsmann, Mickaël ULg; Dellaert, B; Dirksen, C et al

in Osteoporosis International (2013), 24(1), 53

Detailed reference viewed: 10 (3 ULg)
Full Text
Peer Reviewed
See detailSubchondral bone and osteoarthritis: biological and cellular aspects
Henrotin, Yves ULg; Pesesse, Laurence ULg; Sanchez, Christelle ULg

in Osteoporosis International (2012), 23(Suppl 8), 847851

Detailed reference viewed: 28 (12 ULg)
Full Text
Peer Reviewed
See detailEfficacy of a strontium ranelate 2 G/vitamin D3 1000 UI combination on the correction of vitamin D insufficiency
Rizzoli, R; Dawson-Hughes, B; Kaufman, JM et al

in Osteoporosis International (2012, May), 23(S2), 225

Detailed reference viewed: 47 (5 ULg)
Full Text
Peer Reviewed
See detailStrontium ranelate reduces the number of radiological or radioclinical progressors in patients with primary knee osteoarthritis
Reginster, Jean-Yves ULg; Chapurlat, R; Christiansen, C et al

in Osteoporosis International (2012, March), 23(S2), 366-367

Detailed reference viewed: 43 (2 ULg)
Full Text
Peer Reviewed
See detailEstablishment of parathyroid hormone (PTH) reference on 10 different assay kits: impact of the recruitment of the population
CAVALIER, Etienne ULg; SOUBERBIELLE, Jean-Claude

in Osteoporosis International (2012, March), 23(Supplement 2), 360

Detailed reference viewed: 17 (1 ULg)
Full Text
Peer Reviewed
See detailStrontium ranelate and risk of venous thromboembolism (VTE) : an update of a retrospective cohort study in the UK general practice research database (GPRD)
Cooper, C; Deltour, N; Speirs, C et al

in Osteoporosis International (2012, March), 23(S2), 364-365

Detailed reference viewed: 64 (3 ULg)
Full Text
Peer Reviewed
See detailDifference between total and intact assays for N-terminal propeptide of type I procollagen in renal impaired patients
CAVALIER, Etienne ULg; CARLISI, Ignazia ULg; ROUSSELLE, Olivier ULg et al

in Osteoporosis International (2012, March), 23(Supplement 2), 339

Detailed reference viewed: 21 (4 ULg)
Full Text
Peer Reviewed
See detailWhat are the most important medication attributes for patients with osteoporosis ? Results from a qualitative study
Hiligsmann, Mickaël ULg; Van Durme, C; Geusens, P et al

in Osteoporosis International (2012, March), 23(S2), 81-82

Detailed reference viewed: 22 (3 ULg)